Previous studies have identified that the miR-34c and the miR-320 act as regulatory molecules of insulin-producing in mesenchymal stem cells or cell proliferation in ovarian tumor cells via targeting to MAPK1 or MAP2K1, respectively (Bai et al., 2017; Xu et al., 2017). Here, MAP2K1 is linked to ovarian neoplasm.